RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Edward C. Bell to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Edward C. Bell has written about Clinical Trials, Phase III as Topic.
Edward C. Bell
Connection Strength
0.041
Clinical Trials, Phase III as Topic
  1. Wren C, Bell E, Eiland LS. Ozenoxacin: A Novel Topical Quinolone for Impetigo. Ann Pharmacother. 2018 12; 52(12):1233-1237.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support